(Q40088673)

17 September 2017

1 reference

title

Lithium treatment in schizophrenia and schizo-affective disorders (English)

1 reference

17 September 2017

Lithium Treatment in Schizophrenia and Schizo-Affective Disorders (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

10 August 2023

1 reference

N. J. Delva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6129016

10 August 2023

F. J. Letemendia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6129016

10 August 2023

language of work or name

English

0 references

publication date

1 October 1982

1 reference

full work available at URL

17 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000112796

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

British Journal of Psychiatry

10 August 2023

published in

1 reference

17 September 2017

volume

141

1 reference

17 September 2017

page(s)

387-400

1 reference

Schizo-affective psychosis: fact or fiction? A survey of the literature

17 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

A new drug treatment for premenstrual exacerbation of schizophrenia

10 August 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Lithium carbonate in schizoaffective states.

10 August 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report

10 August 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

10 August 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Lithium Prophylaxis in Recurrent Affective Disorders

10 August 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study

10 August 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Factors Associated with Poor Response to Lithium Carbonate: A Clinical Study

10 August 2023

12

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Morbidity suppressive effect of lithium carbonate in cycloid psychosis

10 August 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Lithium in treatment failures

10 August 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

A Controlled Study of Lithium vs. Chlorpromazine in Acute Schizophrenics

10 August 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Target symptoms in lithium carbonate therapy.

10 August 2023

17

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

The use of lithium salts in the treatment of manic states.

10 August 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

The treatment of manic psychoses by the administration of lithium salts

10 August 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

The long-term use of lithium in aggressive prisoners.

10 August 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders

10 August 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Lithium carbonate: a clinical study.

10 August 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

The effectiveness of lithium in affective and schizo-affective psychoses

10 August 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Antipsychotic effects of lithium in schizophrenia

10 August 2023

31

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Trials of Lithium, Chlorpromazine and Amitriptyline in Schizoaffective Patients

10 August 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Lithium salts in the treatment of psychotic excitement

10 August 2023

33

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Lithium ion: a specific psychopharmacological approach to the treatment of mania

10 August 2023

34

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Differential response to lithium carbonate in manic depressive and schizo-affective disorders

10 August 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States

10 August 2023

41

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

The lithium treatment of maniacal psychosis

10 August 2023

43

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

10 August 2023

44

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

10 August 2023

45

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

Some observations on the use of lithium carbonate

10 August 2023

49

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

10 August 2023

Lithium in schizophrenia

50

1 reference

https://api.crossref.org/works/10.1192/BJP.141.4.387

10 August 2023

Identifiers

1 reference

17 September 2017

1 reference